2004, Number s2
<< Back Next >>
Arch Cardiol Mex 2004; 74 (s2)
Restenosis: Prevention and treatment
Macaya C
Language: Spanish
References: 10
Page: 406-409
PDF size: 50.61 Kb.
ABSTRACT
Coronary restenosis after angioplasty has been considered as a main sequel to be resolved so success can be guaranteed. Stents procedures represent a partial solution which is favored with the application of drug-releasing stents of drugs such as sirolymus and taxol.
REFERENCES
Serruys PW, de Jaegere P, Kiemeneij F, et al: A comparison of balloon expandable-stent implantation with ballon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
Hoffmann R, Mintz GS, Dussaillant Gr, et al: Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.
de Feyter PJ, Vos J, Rensing BJ: Anti-restenosis trials. Curr Inter Cardiol Rep 2000; 2: 326-31.
Suzuki T, Kopia G, Hayashi S, et al: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-93.
Sousa JE, Costa MA, Abizaid A, et al: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-5.
Sousa JE, Costa MA, Sousa AG, et al: Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107: 381-383.
Marie Claude Morice, Patrick W. Serruys J, Eduardo Sousa, et al: N Engl J Med 2002; 346: 1773-80.
Park SJ, Shim WH, Ho DS, et al: A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537-1545.
Moses JW, Leon MB, Popma JJ, et al: Sirolimus eluting stents versus standard stents in patients with restenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
Schofer J, Schulter M, Gershlich AH, et al: Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.